Biogen Inc. buy Piper Sandler
Start price
14.02.24
/
50%
€207.20
Target price
14.02.25
€302.90
Performance (%)
-35.45%
End price
15.02.25
€133.75
Summary
This prediction ended on 15.02.25 with a price of €133.75. Massive losses of -35.45% were the result for the BUY prediction by Piper_Sandler. Piper_Sandler has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -0.438% | -0.438% | 41.855% |
| iShares Core DAX® | -2,80 % | -1,40 % | -0,22 % |
| iShares Nasdaq 100 | -6,35 % | -0,41 % | 29,00 % |
| iShares Nikkei 225® | -6,94 % | -0,28 % | 48,21 % |
| iShares S&P 500 | -3,41 % | 0,40 % | 20,28 % |
Comments by Piper_Sandler for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Piper Sandler from $350.00 to $325.00. They now have an "overweight" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten